Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients. [electronic resource]
Producer: 20150729Description: 950-60 p. digitalISSN:- 1365-2125
- Adult
- Aged
- Anthracyclines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers -- blood
- Breast Neoplasms -- drug therapy
- Cardiotonic Agents -- administration & dosage
- Cardiotoxicity -- diagnosis
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Echocardiography
- Electrocardiography
- Female
- Free Radical Scavengers -- administration & dosage
- Humans
- Injections, Intravenous
- Middle Aged
- Natriuretic Peptide, Brain -- blood
- Netherlands
- Peptide Fragments -- blood
- Phosphatidylcholines -- administration & dosage
- Superoxide Dismutase -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.